Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC) Meeting Abstract


Authors: Morris, P. G.; Iyengar, N. M.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R. J.; Steingart, R.; Oeffinger, K. C.; Lin, N.; Moy, B.; Come, S. E.; Winer, E. P.; Norton, L.; Hudis, C.; Dang, C. T.
Abstract Title: Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Start Page: 630
Language: English
ACCESSION: WOS:000335419600135
PROVIDER: wos
Notes: Meeting Abstract: 630 -- Source: Wos
MSK Authors
  1. Sujata Patil
    383 Patil
  2. Patrick Glyn Morris
    107 Morris
  3. Clifford Hudis
    840 Hudis
  4. Larry Norton
    563 Norton
  5. Chau Dang
    156 Dang
  6. Richard M Steingart
    113 Steingart
  7. Kevin Oeffinger
    255 Oeffinger
  8. Carol Chen
    25 Chen
  9. Neil Mukund Iyengar
    63 Iyengar
  10. Robert James Lehman
    9 Lehman